Agent Orange as a risk factor for high-grade prostate cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Agent Orange as a risk factor for high-grade prostate cancer

Published:2013-05-13 Issue:13 Volume:119 Page:2399-2404
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Ansbaugh Nathan¹,Shannon Jackilen¹²³⁴,Mori Motomi⁴,Farris Paige E.²,Garzotto Mark³⁴⁵

Affiliation:

1. Public Health and Preventive Medicine; Oregon Health and Science University; Portland Oregon

2. Oregon Health and Science University Center for Research on Occupational and Environmental Toxicology; Portland Oregon

3. Division of Urology; Portland Veterans Affairs Medical Center; Portland Oregon

4. Oregon Health and Science University Knight Cancer Institute; Portland Oregon

5. Departments of Urology and Radiation Medicine; Oregon Health and Science University; Portland Oregon

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.27941/fullpdf

Reference13 articles.

1. Scandinavian Prostate Cancer Group Study No 4. Radical prostatectomy versus watchful waiting in early prostate cancer;Bill-Axelsson;N Engl J Med,2005

2. PLCO Project Team. Mortality results from a randomized prostate-cancer screening trial;Andriole;N Engl J Med,2009

3. ERSPC Investigators. Screening and prostate-cancer mortality in a randomized European study;Schroder;N Engl J Med,2009

4. Screening for prostate cancer: US Preventive Services Task Force recommendation statement;Moyer;Ann Intern Med,2012

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Agent Orange exposure and prostate cancer risk in the Million Veteran Program;2023-06-16

2. The Lethal and Sub-Lethal Effects of Fluorinated and Copper-Based Pesticides—A Review;International Journal of Environmental Research and Public Health;2023-02-19

3. Agent Orange and Cancer;Environmental Oncology;2023

4. Endocrine-disrupting chemicals (EDCs) and cancer: new perspectives on an old relationship;Journal of Endocrinological Investigation;2022-12-16

5. Racial disparities in prostate cancer: A complex interplay between socioeconomic inequities and genomics;Cancer Letters;2022-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3